3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Depression
4
Neoplasms
3
Neoplasm Metastasis
3
Anxiety Disorders
3
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Osteosarcoma
1
Opioid-Related Disorders
1
Melanoma
1
Lymphoma
1
Hospice
1
Hematopoietic and Lymphatic System Neoplasm
1
Hematologic Neoplasms
1
Gastrointestinal Neoplasms
1
Endocrine Gland Neoplasms
1
Depressive Disorder, Major
1
Depressive Disorder
1
Caregiver Distress
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Biliary Tract Neoplasms
1
Agnosia
1
Interventions
abacavir
1
Saline Solution
1
Psilocybin
1
Infliximab
1
Antidepressive Agents
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Depressive Disorder, Major
×
Psilocybin
×
1 year
×
Clear all
NCT05947383
2026-05-06
2Dose
Sunstone Medical
Phase 2
Active not recruiting
56 enrolled